Joel A. Saydoff

638 total citations
28 papers, 536 citations indexed

About

Joel A. Saydoff is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Joel A. Saydoff has authored 28 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Joel A. Saydoff's work include Pain Mechanisms and Treatments (8 papers), Mitochondrial Function and Pathology (6 papers) and Neuropeptides and Animal Physiology (5 papers). Joel A. Saydoff is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Mitochondrial Function and Pathology (6 papers) and Neuropeptides and Animal Physiology (5 papers). Joel A. Saydoff collaborates with scholars based in United States, Sweden and Switzerland. Joel A. Saydoff's co-authors include Mark S. Brownfield, Louis D. Van de Kar, Peter A. Rittenhouse, Molly Carnes, Mark D. Lindner, Zhongyi Hu, Rolando A.G. Garcia, Reid W. von Borstel, Patrick Aebischer and Eric Buchser and has published in prestigious journals such as Journal of Clinical Oncology, Brain Research and Pain.

In The Last Decade

Joel A. Saydoff

27 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel A. Saydoff United States 14 281 190 182 86 66 28 536
A. N. Chepkova Germany 14 337 1.2× 195 1.0× 259 1.4× 124 1.4× 161 2.4× 34 891
Anne‐Sophie Wattiez United States 16 211 0.8× 293 1.5× 122 0.7× 59 0.7× 32 0.5× 31 734
Raymond H. Abhold United States 14 322 1.1× 109 0.6× 265 1.5× 74 0.9× 54 0.8× 21 647
Siân Lewis United States 7 296 1.1× 284 1.5× 242 1.3× 35 0.4× 65 1.0× 107 670
T Ibuki Japan 5 223 0.8× 300 1.6× 90 0.5× 48 0.6× 40 0.6× 8 471
Perrine Inquimbert France 12 291 1.0× 339 1.8× 215 1.2× 42 0.5× 21 0.3× 21 593
S. Lortet France 11 231 0.8× 71 0.4× 199 1.1× 30 0.3× 57 0.9× 30 553
P. J. Norris United Kingdom 6 227 0.8× 236 1.2× 145 0.8× 86 1.0× 28 0.4× 9 532
Kelly J. Powell Canada 11 487 1.7× 405 2.1× 256 1.4× 30 0.3× 32 0.5× 17 770
Yuan‐Feen Tsai Taiwan 14 189 0.7× 65 0.3× 102 0.6× 58 0.7× 60 0.9× 36 553

Countries citing papers authored by Joel A. Saydoff

Since Specialization
Citations

This map shows the geographic impact of Joel A. Saydoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel A. Saydoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel A. Saydoff more than expected).

Fields of papers citing papers by Joel A. Saydoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel A. Saydoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel A. Saydoff. The network helps show where Joel A. Saydoff may publish in the future.

Co-authorship network of co-authors of Joel A. Saydoff

This figure shows the co-authorship network connecting the top 25 collaborators of Joel A. Saydoff. A scholar is included among the top collaborators of Joel A. Saydoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel A. Saydoff. Joel A. Saydoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia, Rolando A.G., Joel A. Saydoff, Michael K. Bamat, & Reid W. von Borstel. (2018). Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency. Toxicology and Applied Pharmacology. 353. 67–73. 2 indexed citations
2.
Saydoff, Joel A., et al.. (2016). Uridine triacetate as an effective antidote in preclinical models of 5-FU overdoses and impaired 5-FU clearance.. Journal of Clinical Oncology. 34(15_suppl). e18232–e18232.
3.
Saydoff, Joel A., Rolando A.G. Garcia, Susan Browne, et al.. (2006). Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease. Neurobiology of Disease. 24(3). 455–465. 23 indexed citations
4.
Saydoff, Joel A., Jin G. Sheng, Zhongyi Hu, et al.. (2005). [P‐188]: PN401 decreases neurodegeneration in models of Alzheimer's, Huntington's and Parkinson's disease, neuroinflammation, excitotoxicity and has antiepileptic activity. Alzheimer s & Dementia. 1(1S_Part_2). 1 indexed citations
5.
Saydoff, Joel A., et al.. (2004). P1-404 Uridine prodrug PN401 has beneficial effects in models of Alzheimer's disease, hypoxia and oxidative stress. Neurobiology of Aging. 25. S213–S213. 2 indexed citations
6.
Klivènyi, Péter, Gabrielle Gardian, Noel Y. Calingasan, et al.. (2004). Neuroprotective Effects of Oral Administration of Triacetyluridine Against MPTP Neurotoxicity. NeuroMolecular Medicine. 6(2-3). 87–92. 11 indexed citations
7.
8.
Hoane, Michael R., et al.. (2002). No detectable analgesic effects in the formalin test even with one million bovine adrenal chromaffin cells. Pain. 99(1). 263–271. 12 indexed citations
9.
Lindner, Mark D., Jonathan M. Francis, & Joel A. Saydoff. (2001). Intrathecal Polymer-Encapsulated Bovine Adrenal Chromaffin Cells Fail to Produce Analgesic Effects in the Hotplate and Formalin Test. Experimental Neurology. 170(1). 225–225. 1 indexed citations
10.
11.
Lindner, Mark D., Jonathan M. Francis, Melissa A. Plone, et al.. (2000). The analgesic potential of intraventricular polymer-encapsulated adrenal chromaffin cells in a rodent model of chronic neuropathic pain.. Experimental and Clinical Psychopharmacology. 8(4). 524–538. 3 indexed citations
12.
Lindner, Mark D., Jonathan M. Francis, & Joel A. Saydoff. (2000). Intrathecal Polymer-Encapsulated Bovine Adrenal Chromaffin Cells Fail to Produce Analgesic Effects in the Hotplate and Formalin Test. Experimental Neurology. 165(2). 370–383. 13 indexed citations
13.
Décosterd, Isabelle, et al.. (1998). Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain. Pain. 76(1). 159–166. 68 indexed citations
14.
Yu, Wei, Jing‐Xia Hao, Xiao‐Jun Xu, et al.. (1998). Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury. Pain. 74(2). 115–122. 56 indexed citations
15.
Emerich, Dwaine F., et al.. (1997). Cellular Delivery of Human Cntf Prevents Motor and Cognitive Dysfunction in a Rodent Model of Huntington's Disease. Cell Transplantation. 6(3). 249–266. 28 indexed citations
16.
Subramanian, Thyagarajan, Dwaine F. Emerich, Roy A.E. Bakay, et al.. (1997). Polymer-Encapsulated PC-12 Cells Demonstrate High-Affinity Uptake of Dopamine in Vitro and 18F-DOPA Uptake and Metabolism after Intracerebral Implantation in Nonhuman Primates. Cell Transplantation. 6(5). 469–477. 12 indexed citations
17.
Saydoff, Joel A., et al.. (1996). Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin. American Journal of Physiology-Endocrinology and Metabolism. 270(3). E513–E521. 33 indexed citations
18.
Saydoff, Joel A. & Robert Zaczek. (1996). Blockade of N- and Q-type Ca2+ channels inhibit K+-evoked [3H]acetylcholine release in rat hippocampal slices. Brain Research Bulletin. 40(4). 283–286. 7 indexed citations
19.
Saydoff, Joel A., Molly Carnes, & Mark S. Brownfield. (1993). The role of serotonergic neurons in intravenous hypertonic saline-induced secretion of vasopressin, oxytocin, and ACTH. Brain Research Bulletin. 32(6). 567–572. 14 indexed citations
20.
Carnes, Molly, et al.. (1990). Effects of Immunoneutralization of Corticotropin-Releasing Hormone on Ultradian Rhythms of Plasma Adrenocorticotropin*. Endocrinology. 126(4). 1904–1913. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. N. Chepkova Breakdown of academic impact, for papers by Anne‐Sophie Wattiez Breakdown of academic impact, for papers by Raymond H. Abhold Breakdown of academic impact, for papers by Siân Lewis Breakdown of academic impact, for papers by T Ibuki Breakdown of academic impact, for papers by Perrine Inquimbert Breakdown of academic impact, for papers by S. Lortet Breakdown of academic impact, for papers by P. J. Norris Breakdown of academic impact, for papers by Kelly J. Powell Breakdown of academic impact, for papers by Yuan‐Feen Tsai
Rankless by CCL
2026